India / Pharma Market to Grow by 12-14% Up to 2023
The USD 41 billion Indian pharma industry, the world’s third largest by volume and 13th largest by value, stands…
GVK BIO, a leading Contract Research & Development Organization – CRDO that services the global Biopharma industry; is headquartered in Hyderabad, India with operations in four sites including California, USA. Established in 2001, GVK BIO has over 16 years of rich experience across the Research and Development value chain with a focus on speed and quality. Our team of over 2000 highly qualified scientists, backed by well-defined and scalable processes, modern facilities and a strong customer-centric partnering approach, focus on bringing our customers’ products to market. We partner with reputed global academic institutions and research laboratories to find efficient, cost-effective and innovative solutions to their Research and Development challenges.
Contact:
Address: GVK Biosciences Private Limited, Plot No. 28 A, IDA Nacharam, Hyderabad –500076, India
Website: http://www.gvkbio.com
Email: corpcomm@gvkbio.com
The USD 41 billion Indian pharma industry, the world’s third largest by volume and 13th largest by value, stands…
Six Indian pharma and biotech firms have joined the global race to develop a vaccine for COVID-19 with…
COVID-19 restrictions have severely hampered multinational pharma companies who rely on India for generics and…
A recent IQVIA report highlights the increasing importance of Indian firms to the USA’s burgeoning generic…
The ongoing coronavirus outbreak and the subsequent shutdown of factories in China is having severe repercussions…
Below is a selection of the top stories in Indian pharma from recent months, ranging from efforts to counter the…
Biocon, the first Indian company to have a biosimilar drug approved in the US, is taking another step forward with…
The state of Gujarat proudly stands as India’s main pharmaceutical hub, accounting for over 33 percent of the…
Unlike many of his pharma peers, Vivek Sharma worked in operations and finance for two decades before joining the…
The pharmaceutical industries of China and India, historically focused on their large domestic markets and exports…
Aditya Bhattacharji is Healthcare Practice Head at Eurasia Group. In this article, he looks at India’s…
Dilip Shah, the Secretary-General of the Indian Pharmaceutical Alliance advocates for a stronger and more…